Skip to main content
China Medical System Holdings Limited logo

China Medical System Holdings Limited — Investor Relations & Filings

Ticker · 867 ISIN · KYG211081248 LEI · 529900Z57DVJXUBLHX66 HKEX Manufacturing
Open in API
Filings indexed 710 across all filing types
Latest filing 2026-04-23 Declaration of Voting R…
Country KY Cayman Islands
Listing HKEX 867

About China Medical System Holdings Limited

http://www.cms.net.cn

China Medical System Holdings Limited (CMS) is an innovation-driven specialty pharmaceutical group engaged in the development, manufacturing, marketing, promotion, and sales of pharmaceutical products. The company focuses on delivering competitive products and services that enhance clinical value in disease diagnosis and treatment. CMS maintains a strong commercial presence in the specialty drug market. Its strategy combines established commercialization capabilities with an active R&D pipeline. A notable component of its pipeline is the self-developed innovative drug CMS-D017, a selective Complement Factor B (CFB) small molecule inhibitor. This drug is being developed for treating complement dysregulation-related inflammatory and autoimmune diseases, including Paroxysmal Nocturnal Hemoglobinuria (PNH).

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT ON VOTING RESULTS OF ANNUAL GENERAL MEETING HELD ON 23 APRIL 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement of the voting results at the company’s Annual General Meeting held on 23 April 2026. It details poll results for each resolution, fulfilling the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-04-23 English
Voluntary and Business Update Announcement New Drug Application for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China
Regulatory Filings Classification · 1% confidence The document is a voluntary business update announcement by China Medical System Holdings Ltd. regarding the acceptance of a new drug application by the NMPA. It contains no financial statements or shareholder vote results; it is not an earnings release, management report, or investor presentation. It is a regulatory announcement under stock exchange rules, serving as general corporate news that does not fit any other specific category. Therefore, the appropriate classification is a Regulatory Filing (RNS).
2026-04-23 English
FORM OF PROXY
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a form of proxy for use by shareholders at the Company’s Annual General Meeting, providing voting instructions and soliciting proxies. This falls squarely under “Proxy Solicitation & Information Statement” (PSI). It is not the AGM notice itself, nor the meeting minutes, but the proxy materials sent to shareholders. Therefore, it should be classified as a PSI.
2026-04-01 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal Notice of Annual General Meeting detailing resolutions to be considered, proxy appointment instructions, record dates, and meeting logistics. It is clearly a meeting solicitation sent to shareholders requesting their votes, rather than the AGM presentation materials or a results announcement. Therefore, it fits the Proxy Solicitation & Information Statement category.
2026-04-01 English
PROPOSALS FOR (1) RE-ELECTION OF THE RETIRING DIRECTORS (2) DECLARATION OF FINAL DIVIDEND (3) GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES AND (4) NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The provided document is a shareholder circular convening the Annual General Meeting, containing the Notice of AGM, proposals for re-election of directors, dividend declaration, general and repurchase mandates, explanatory appendices, and proxy form instructions. It is clearly a solicitation of proxies and information statement for shareholders’ votes at the AGM. This matches our definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-01 English
Environmental, Social and Governance Report 2025
Environmental & Social Information Classification · 1% confidence The document is a full Environmental, Social and Governance (ESG) Report covering the company’s ESG strategy, governance structure, stakeholder communication, environmental and social performance metrics, and related disclosures for the 2025 fiscal year. It is neither a brief announcement nor a financial report, but a detailed ESG report in line with HKEX and SGX ESG reporting codes. This matches the definition for Environmental & Social Information (ESR).
2026-04-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.